- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04917471
Effect of Nitrate on Red Blood Cell Function in Type 2 Diabetes
March 27, 2023 updated by: John Pernow, Karolinska Institutet
The Effect of Dietary Nitrate Supplementation on Red Blood Cell Function in Patients With Type 2 Diabetes
To investigate the effect of nitrate supplementation on red blood cell function in patients with type 2 diabetes.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Anticipated)
20
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: John Pernow
- Phone Number: +46704848361
- Email: john.pernow@ki.se
Study Locations
-
-
-
Stockholm, Sweden, 17176
- Recruiting
- Karolinska Institutet, Karolinska University Hospital
-
Contact:
- John Pernow, Dr
- Phone Number: +46851775876
- Email: john.pernow@ki.se
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
Type 2 diabetes
Exclusion Criteria:
Acute coronary syndrome Vegetarian diet Impaired renal function Absolute indication for proton pump inhibitor Ongoing treatment with organic nitrate Heart failure (ejection fraction <35%) Any condition that interferes with the possibility to fulfill the study protocol
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Quadruple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Nitrate-rich beet root juice
Nitrate-rich Beet root juice 70 ml bid
|
70 ml bid
|
Placebo Comparator: Placebo
Nitrate-depleted beet root juice 70 ml bid
|
70 ml bid
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Percentage recovery of left ventricular function
Time Frame: 1 week
|
Red blood cells are administered to an isolated rodent heart subjected to 25 min global ischemia and 60 min reperfusion.
The percentage recovery during reperfusion is determined.
|
1 week
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: John Pernow, Karolinska Institutet
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
June 1, 2021
Primary Completion (Anticipated)
June 30, 2024
Study Completion (Anticipated)
December 31, 2024
Study Registration Dates
First Submitted
May 25, 2021
First Submitted That Met QC Criteria
June 7, 2021
First Posted (Actual)
June 8, 2021
Study Record Updates
Last Update Posted (Actual)
March 28, 2023
Last Update Submitted That Met QC Criteria
March 27, 2023
Last Verified
March 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- NOBLE-DM
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Type 2 Diabetes
-
University of Erlangen-Nürnberg Medical SchoolCompletedType 2-diabetesGermany
-
Antonio Di MauroCompletedType-2 DiabetesItaly
-
DiaMedica Therapeutics IncCompletedDiabetes Type 2Netherlands
-
RenJi HospitalUnknownType 2 Diabetes.China
-
CSPC Baike (Shandong) Biopharmaceutical Co., Ltd.Not yet recruiting
-
Beijing Chao Yang HospitalNot yet recruitingType 2 Diabetes MellitusChina
-
Vinmec Research Institute of Stem Cell and Gene...CompletedType 2 Diabetes MellitusVietnam
-
Tehran University of Medical SciencesCompleted
-
Insulet CorporationCompletedType 2 Diabetes MellitusUnited States
-
Seoul National University Bundang HospitalAstellas Pharma Korea, Inc.CompletedType 2 Diabetes MellitusKorea, Republic of
Clinical Trials on Beet root juice
-
University of VirginiaCompletedArterial Stiffness | Vascular DilationUnited States
-
University of VirginiaCompletedHealthyUnited States
-
University of VirginiaRecruitingPeripheral Arterial Disease | Peripheral Vascular DiseasesUnited States
-
Wake Forest UniversityRecruitingHealthy Aging | Health Care UtilizationUnited States
-
Indiana UniversityCompletedSarcopenia | AgingUnited States
-
University of Kansas Medical CenterCompleted
-
Royal Surrey County Hospital NHS Foundation TrustUnknownColorectal Cancer
-
Wake Forest University Health SciencesNational Heart, Lung, and Blood Institute (NHLBI); Wake Forest UniversityWithdrawn
-
Penn State UniversityCompletedPostmenopausal WomenUnited States
-
Wake Forest University Health SciencesCompletedStroke | Ischemic Stroke | Cerebrovascular AccidentUnited States